Progyny, Inc. (PGNY) — closed signal from July 8, 2025
Partial Published before the outcome was known, scored automatically when the window closed on October 6, 2025.
Predicted vs. what happened
What happened
Reached 27% of the predicted growth at its peak, without hitting the target.
The thesis — published July 8, 2025
Progyny jumped after securing a $200 million credit line and telling investors that April-June sales should beat earlier goals. Excitement is very high and recent average price momentum is strong, but profits are still thin because the company is spending heavily to grow. Several Wall Street firms raised their views, and the stock just moved above a two-year slide. If the price cools a little, a gain of 30% or more is possible, yet the shares look a bit expensive, so we are watching rather than rushing in.
Primary drivers
- $200M credit line plus higher spring forecasts strengthen cash picture
- Very strong buying interest from big investors shown by high sentiment score
- New higher target prices from Leerink and BTIG raise the stock's profile
- Price finally pushed above a two-year slide on big trading volume
How it played out
PGNY: target was not reached
On July 8, 2025, Lyra published a short-term thesis on PGNY at $24.31. It expected 32% growth. The thesis pointed to a $200 million credit line, higher spring forecasts, strong buying interest from big investors, higher target prices from Leerink and BTIG, and a move above a two-year slide on big trading volume.
Inside the July 8, 2025 to October 6, 2025 window, PGNY peaked at $26.38 on August 8, 2025, a gain of 8.5%. It stayed below the $32.08 target. The window ended at $20.19. The thesis partially played out on an early rise, but it missed the target.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.